Table 7 |
|||
|
Sensitivity analysis |
|||
|
Parameter varied |
Incremental Costs (IVIG-corticosteroids) |
Incremental QALYs (IVIG-corticosteroids |
$/QALY IVIG vs. corticosteroids |
|
|
|||
|
Patient Weight |
|||
|
35 kg |
$58,102 |
0.177 |
$327,665 |
|
45 kg |
$74,043 |
0.177 |
$417,569 |
|
55 kg |
$89,985 |
0.177 |
$507,474 |
|
65 kg |
$105,927 |
0.177 |
$597,378 |
|
75 kg |
$121,869 |
0.177 |
$687,282 |
|
85 kg |
$137,810 |
0.177 |
$777,186 |
|
95 kg |
$153,752 |
0.177 |
$867,090 |
|
Starting Age |
|||
|
35 years old |
$122,293 |
0.178 |
$686,130 |
|
45 years old |
$122,077 |
0.178 |
$686,759 |
|
55 years old |
$121,504 |
0.177 |
$687,371 |
|
65 years old |
$119,999 |
0.176 |
$683,643 |
|
75 years old |
$116,182 |
0.170 |
$683,219 |
|
Discount rate |
|||
|
0% |
$126,340 |
0.185 |
$682,390 |
|
3% |
$123,542 |
0.180 |
$685,346 |
|
Model time horizon |
|||
|
1 year |
$59,546 |
0.078 |
$764,917 |
|
3 years |
$102,457 |
0.146 |
$702,569 |
|
5 years |
$121,869 |
0.177 |
$687,282 |
|
10 years |
$139,986 |
0.209 |
$670,396 |
|
20 years |
$143,690 |
0.218 |
$658,267 |
|
Incremental IVIG utility gain = 0.25 |
$121,869 |
0.364 |
$335,038 |
|
Assume corticosteroid patients switch to IVIG after adverse event |
$113,444 |
0.166 |
$682,309 |
|
Relapse rate for IVIG not extrapolated beyond 25 weeks |
$173,189 |
0.257 |
$672,616 |
|
Maintenance IVIG dose and frequency |
|||
|
1.0 mg/kg every 3 weeks |
$121,869 |
0.177 |
$687,282 |
|
1.0 mg/kg every 6 weeks |
$65,304 |
0.177 |
$368,284 |
|
1.0 mg/kg every 8 weeks |
$51,163 |
0.177 |
$288,535 |
|
0.4 mg/kg every 3 weeks |
$55,661 |
0.177 |
$313,905 |
|
0.4 mg/kg every 6 weeks |
$32,200 |
0.177 |
$181,595 |
|
0.4 mg/kg every 8 weeks |
$26,335 |
0.177 |
$148,518 |
|
|
|||
|
Blackhouse et al. Cost Effectiveness and Resource Allocation 2010 8:14 doi:10.1186/1478-7547-8-14 |
|||